NOVONIX (ASX:NVX) just hit a major milestone by delivering its first commercial-grade synthetic graphite sample for industrial uses to a leading North American carbon processor. This marks a step forward in expanding its manufacturing reach.

See our latest analysis for NOVONIX.

This latest milestone comes as momentum returns to NOVONIX’s share price, with a sharp 31.5% 7-day gain and a 53% rally over the past three months. This suggests that investor optimism could be building around its scaling efforts and market expansion plans. Looking at the bigger picture, however, longer-term total shareholder return is still down considerably, with a decline of 31% in the past year and 66% over three years. As a result, recent enthusiasm marks a potential turning point rather than a full recovery.

If NOVONIX’s surge has you curious about where opportunity may strike next, consider broadening your search and discovering fast growing stocks with high insider ownership

With shares rebounding and new commercial milestones reached, does NOVONIX now trade at a discount after last year’s decline, or has the stock already priced in the next stage of growth?

Price-to-Sales of 45.1x: Is it justified?

NOVONIX currently trades at a price-to-sales (P/S) ratio of 45.1, based on its last close, making it appear much more expensive than its industry peers and the broader market.

The price-to-sales ratio measures how much investors are paying for each dollar of sales generated by the company. It is especially relevant for high-growth or unprofitable companies, like NOVONIX, where earnings are not positive and revenue growth becomes the main metric to gauge future potential.

While investors may hope this premium reflects NOVONIX's projected growth, the company is unprofitable and its current P/S multiple is much higher than the global electronics industry average of 1.8 and the peer average of 14. However, compared to the estimated fair price-to-sales ratio of 126.5, the current market pricing could have even more room to move higher if growth materializes as expected.

Explore the SWS fair ratio for NOVONIX

Result: Preferred multiple of 45.1x (OVERVALUED)

However, continued unprofitability and reliance on high revenue growth could pose challenges if market conditions change or expectations are not met.

Find out about the key risks to this NOVONIX narrative.

Build Your Own NOVONIX Narrative

If you want to approach the story differently or dig into the numbers on your own terms, you can shape your own view of NOVONIX in just a few minutes, so why not Do it your way

Story Continues

A great starting point for your NOVONIX research is our analysis highlighting 1 key reward and 4 important warning signs that could impact your investment decision.

Looking for more investment ideas?

There’s no need to limit your search to just one company when smarter opportunities may be one click away. Give yourself the edge and check out:

Spot high yields and lock in consistency by using these 19 dividend stocks with yields > 3% to see which companies deliver robust payouts beyond the ordinary. Tap into fast-moving innovations by scanning these 25 AI penny stocks to pinpoint businesses at the forefront of artificial intelligence breakthroughs. Unearth solid value by reviewing these 889 undervalued stocks based on cash flows, which features companies trading below their cash flow potential and gives you a head start on tomorrow’s winners.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NVX.AX.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments